Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;15(2):2266626.
doi: 10.1080/19490976.2023.2266626. Epub 2023 Oct 16.

Mitochondrial dysfunction-associated microbiota establishes a transmissible refractory response to anti-TNF therapy during ulcerative colitis

Affiliations

Mitochondrial dysfunction-associated microbiota establishes a transmissible refractory response to anti-TNF therapy during ulcerative colitis

Ainize Peña-Cearra et al. Gut Microbes. 2023 Dec.

Abstract

Anti-TNF therapy can induce and maintain a remission status during intestinal bowel disease. However, up to 30% of patients do not respond to this therapy by mechanisms that are unknown. Here, we show that the absence of MCJ, a natural inhibitor of the respiratory chain Complex I, induces gut microbiota changes that are critical determinants of the lack of response in a murine model of DSS-induced inflammation. First, we found that MCJ expression is restricted to macrophages in human colonic tissue. Therefore, we demonstrate by transcriptomic analysis of colon macrophages from DSS-induced mice that MCJ-deficiency is linked to the expression of genes belonging to the FcγR signaling pathway and contains an anti-TNF refractory gene signature identified in ulcerative colitis patients. The gut microbial composition changes observed upon DSS treatment in the MCJ-deficient mice revealed the increased presence of specific colitogenic members, including Ruminococcus gnavus and Oscillospira, which could be associated with the non-response to TNF inhibitors. Further, we show that the presence of a microbiota associated resistance to treatment is dominant and transmissible to responsive individuals. Collectively, our findings underscore the critical role played by macrophage mitochondrial function in the gut ecological niche that can substantially affect not only the severity of inflammation but also the ability to successfully respond to current therapies.

Keywords: FcγR signaling; IBD; anti-TNF therapy; complex I; microbiota; mitochondriopathy.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

None
Graphical abstract
Figure 1.
Figure 1.
In vivo anti-TNF therapeutic response. WT and MCJ-KO mice were treated the first 6 d with DSS and infliximab (IFX) was administrated orally from day 3 to day 6, followed by 3 d of recovery period. All groups are positive for DSS. (a) Weight loss (%) (n = 8 mice per group at minimum). Statistical differences (P value < .05) were observed between WT IFX- and WT IFX+ from day 3 onward (asterisks below WT IFX+ line) and between MCJ KO IFX+ and WT IFX+ at day 3 and from day 5 onward (asterisks above WT IFX- line). (b) Histological scores and representative images of colon tissue (scale bar size, 100 µm). (c) TACE activity in colonic protein extracts (Rfu/mg protein). For statistical analysis two-way ANOVA was performed. Within boxplots, asterisks above boxes versus control genotype (IFX+ versus IFX-) and asterisks above line versus different genotypes in the same experimental group. (Wt_ifxn and MCJ KO_IFXn: DSS positive and IFX negative; WT_IFXp and MCJ KO_IFXp: DSS and IFX positive).
Figure 2.
Figure 2.
Transcriptomic analysis of intestinal tissue macrophages. (a) Immunofluorescence of MCJ (red) and CD163 (green) in inflamed and healthy adjacent colon tissue from IBD patients. Colocalization is represented in yellow. (b) Principal component analysis showing differences between WT and MCJ-deficient DSS positive colon macrophages´ transcriptomes. (c) HOMER identified several transcription factors enriched in DSS-induced MCJ-KO colon macrophages. (d) venn diagram representing 339 differentially expressed genes found in colon macrophages due to MCJ-KO and a human core rectal UC gene expression signature consisting of 5296 genes. Out of 305 genes upregulated in colitis induced MCJ-deficient mice colon macrophages, 183 were shared with the human UC gene signature. (e) venn diagram showing shared genes between upregulated genes due to MCJ-KO in DSS-induced mice colon macrophages and patients refractory to anti-TNF and corticosteroid treatments.
Figure 3.
Figure 3.
Functional annotation enrichment analysis of inflamed intestinal macrophages according to MCJ levels. RNA-seq data analysis shows 305 upregulated and 34 downregulated genes in MCJ-KO mice treated with DSS compared to control colitis mice (FDR <0.05 and fold change ≥1.5). ClueGO charts related to immunological function reveals (a) upregulation of FCγR signaling pathway (46,7%) in MCJ-KO colitis mice compared to WT colitis (Log2 > 2, P value < 0.05) and (b) downregulation of chaperone cofactor refolding (50%) and microtubule polymerization (50%). Detailed functional annotation enrichment analyses of (c) 305 upregulated and (c) 34 downregulated genes in MCJ-KO colitis mice using ToppGene, ToppCluster and Cytoscape are represented. (c) Pathways related to upregulated genes; immune system (purple), cytokines (orange), cell adhesion and migration (yellow) and other pathways (green). (d) Biological processes enriched by downregulated genes; mitochondrial respiration (blue), cytokines (orange), NOD-like receptors, the intracellular sensors of PAMPS (purple) and heat acclimation (red). (e) Fecal live bacteria percentage (n = 3) and (f) fecal IgG-coated bacteria percentage obtained by flow cytometer (n = 3). For statistical analysis two-way ANOVA was used.
Figure 4.
Figure 4.
Heatmap of Spearman´s rank correlation coefficients. Bacterial abundances from the 4 experimental groups that were not treated with antibiotic and genes modified by the level of MCJ in colon macrophages upon intestinal inflammation (DSS+) were used. To find associations hierarchical all against all association (HAIIA) was performed. A. muciniphila correlates with Jak2 and R. gnavus with Cst7. The numbers indicate the highest correlation between bacteria and gene expression, having number 1 the highest correlation. Red color illustrates positive correlation and blue negative. In the x axis each column shows a different gene and in the y axis each row shows different bacterial species; Firmicutes (black font), Proteobacteria (red), bacteroidetes (blue), actinobacteria (green) and Verrucomicrobia (purple).
Figure 5.
Figure 5.
Microbiota composition impact on the anti-TNF therapeutic efficacy. (a) stacked bar plot representation of the relative abundances of colon content taxa at phylum level. (b) differentially abundant OTUs identified through DESeq2 testing (p.Adj <0.05) between WT and MCJ-KO mice treated with anti-TNF agents (WT_P vs MCJ-KO_P). Each point represents a single OTU colored by phylum and grouped by taxonomic family, and point´s size reflect the mean abundance of the sequenced data. To allow microbial transmission between genotypes, WT and MCJ-KO animals were cohoused during 4 weeks prior to colitis induction. (c) weight loss percentage shown as means ± SEM. Asterisks (*) above the line indicate statistical differences between WT and MCJ-KO mice housed alone. Asterisk (*) below the line shows significant differences between WT mice housed alone or cohoused. (d) colonic length (cm). Within boxplots, asterisks above boxes versus control genotype (cohoused versus alone) and asterisks above line versus different genotypes in the same experimental group. Two-way ANOVA (c, e, f) and (d) Mann-Whitney U test were used for statistical analysis. All experimental groups are DSS+ and IFX+.

Similar articles

Cited by

References

    1. Gisbert JP, Chaparro M.. Primary failure to an anti-TNF agent in inflammatory bowel disease: switch (to a second anti-TNF agent) or swap (for another mechanism of action)? J Clin Med. 2021;10(22):5318. doi:10.3390/jcm10225318. - DOI - PMC - PubMed
    1. Gerriets V, Goyal A, Khaddour K. Tumor necrosis factor inhibitors. Florida: StatPearls. Treasure Island (FL); 2022. - PubMed
    1. Haberman Y, Karns R, Dexheimer PJ, Schirmer M, Somekh J, Jurickova I, Braun T, Novak E, Bauman L, Collins MH, et al. Ulcerative colitis mucosal transcriptomes reveal mitochondriopathy and personalized mechanisms underlying disease severity and treatment response. Nat Commun. 2019;10(1):38. doi:10.1038/s41467-018-07841-3. - DOI - PMC - PubMed
    1. Mottawea W, Chiang CK, Muhlbauer M, Starr AE, Butcher J, Abujamel T, Deeke SA, Brandel A, Zhou H, Shokralla S, et al. Altered intestinal microbiota–host mitochondria crosstalk in new onset Crohn’s disease. Nat Commun. 2016;7(1):13419. doi:10.1038/ncomms13419. - DOI - PMC - PubMed
    1. Peloquin JM, Goel G, Villablanca EJ, Xavier RJ. Mechanisms of pediatric inflammatory bowel disease. Annu Rev Immunol. 2016;34(1):31–16. doi:10.1146/annurev-immunol-032414-112151. - DOI - PubMed

Publication types

Substances